Brief: Fusion Antibodies H1 Pretax Profit GBP -1.42 Mln
04/12/2023 07:23
Dec 4 (Reuters) - Fusion Antibodies H1 net income GBP -1.357 million. * H1 gross profit GBP -84 thousand * H1 basic EPS GBP -2.3 * H1 pretax profit GBP -1.42 million * H1 revenue GBP 541 thousand * H1 EBIT GBP -1.419 million
Recent news on Fusion Antibodies
See all newsBrief: Fusion Antibodies Announces New TGE And Cryoem Project With US Pharma Client
Fusion Antibodies - Contract win
Fusion Antibodies - AGM statement H1 trading and research update
RCS - Fusion Antibodies - Launch of new customer-focused website
Fusion Antibodies - Posting of Annual Report & Notice of AGM